Richard D'Amato
Co-founder

RiseNow provides virtual and in‑person autism evaluations for children ages 0‑6 in Pennsylvania, New Jersey, and Delaware, delivering diagnoses in as little as four weeks using the FDA‑approved Cognoa Canvas Dx platform. After diagnosis, families receive personalized recommendations and ongoing support from a Board‑Certified Behavior Analyst, including parent training and coordinated care with therapists. The HIPAA‑compliant telehealth model expands access to timely, expert assessment and early intervention for underserved families.
Co-founder
Families with children suspected of autism often face long waitlists and limited access to specialized evaluations, causing delays in early intervention during critical developmental periods.
RiseNow Autism Innovations offers virtual and in‑person autism evaluations that can be completed in as little as four weeks. The service uses the FDA‑authorized Cognoa Canvas Dx platform, enabling licensed clinicians to conduct reliable, AI‑enhanced assessments remotely. After diagnosis, families receive personalized recommendations and ongoing support from a dedicated Board‑Certified Behavior Analyst (BCBA), including parent training and coordinated care with therapists and schools. The telehealth model expands reach to rural and underserved areas across Pennsylvania, New Jersey, and Delaware, while in‑person clinics provide face‑to‑face testing and therapy. All interactions are HIPAA‑compliant, with encrypted data handling and insurance navigation assistance.
Primary customers are parents of children ages 18 months to 6 years in Pennsylvania, New Jersey, and Delaware seeking timely autism diagnosis and early intervention services.